Author "rgunnam" Page



Author Nick: rgunnam
Name: Rajesh Gunnam
Site: http://www.globaldata.com


Author Articles List:

Sort by:

Biotech M&A and Licensing Strategies – Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines

Acquisitions contributed to 71.7% of global M&A deals while mergers contributed to only 2.8%. Asset transaction contributed to and private [...]

Lubricants Industry to 2015 – Surge in Automotive Market in Emerging Economies Driving Demand

Lubricants Industry to 2015 – Surge in Automotive Market in Emerging Economies Driving Demand The global automotive industry is back [...]

Top 10 Healthcare Trends in 2011

Globally, cancer is one of the leading causes of death next only to cardiovascular diseases. The global oncology therapeutics market [...]

Clinical Trial Endoints in Oncology – Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology

The primary endpoint for the approval of drugs in the oncology markets, which included colorectal, ovarian, head, neck and prostate [...]

The Future of the Asia – Pacific Power Market to 2020

China emerges as the largest power market by installed capacity among the Asia – Pacific countries with a share of [...]

Growth Hormone Deficiency (GHD) – Pipeline Analysis and Market Forecasts to 2016

The global Growth Hormone Deficiency (GHD) therapeutics market was worth $2.2 billion in 2009. The market is expected to grow [...]

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016

GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of [...]

Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

In 2009, the global renal dialysis equipment market was valued at $5,487m and is forecast to grow at a Compounded [...]

Hepatitis C – Drug Pipeline Analysis and Market Forecasts to 2016

GlobalData’s analysis suggests that the global hepatitis C market was worth $4.4 billion in 2009. It is forecast to grow [...]

Hemophilia – Drug Pipeline Analysis and Market Forecasts to 2016

GlobalData’s analysis suggests that the global hemophilia market was valued at $6.5 billion in 2009. This slow growth is primarily [...]